Cleerly ISCHEMIA vs Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers real-time AI analysis during auscultation, seamlessly integrating into a clinician's existing workflow with no additional steps or separate portals, providing immediate insights at the point of care. This direct, real-time feedback during a routine physical exam, coupled with guided exam workflows and EMR integration, makes it highly usable for a broad range of clinicians. Cleerly ISCHEMIA, while offering interactive web reports, is a post-scan analysis tool that requires data transfer via a proxy, suggesting a less immediate and more specialized workflow.

Both tools offer significant clinical value by being FDA-cleared and addressing critical cardiac conditions with high accuracy. Cleerly ISCHEMIA provides deep, comprehensive insights into coronary artery disease, including plaque characteristics and non-invasive FFR estimation, which can guide personalized treatment and reduce invasive procedures. EFAST, on the other hand, offers real-time, point-of-care detection of structural murmurs and AFib during routine physical exams, enabling earlier detection and intervention for a broader patient population. Their value is high but in different clinical contexts and stages of patient care.

While both require contacting for specific pricing, EFAST offers more transparency by indicating a subscription-based model, yearly Eko+ membership, and a daily cost equivalent for its associated hardware. This provides a clearer understanding of potential costs for individual practitioners or smaller clinics, and the free trial with stethoscope purchase enhances its perceived value. Cleerly ISCHEMIA's pricing is entirely opaque, stating it varies by provider and requires consultation.

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements. Cleerly ISCHEMIA's use of a Cleerly Proxy for data transfer and integration with PowerScribe indicates robust security and workflow integration for imaging-heavy environments. EFAST's cloud-based SaMD deployment with EMR integration and data storage in AWS S3 also signifies readiness for scalable and secure deployment across various clinical settings.

EFAST represents a significant innovation by transforming the traditional stethoscope into an AI-powered diagnostic tool that provides real-time, actionable insights during routine physical exams. Its status as the first FDA-cleared foundation model for cardiovascular AI underscores its pioneering approach. While Cleerly ISCHEMIA offers advanced non-invasive FFR estimation and detailed plaque characterization, EFAST's integration of AI into a ubiquitous point-of-care device for immediate screening holds a broader and more disruptive innovative edge.

Cleerly provides dedicated client support channels with specified hours of operation (Monday to Friday, 10 am ET to 6 pm ET) and a clear process for existing users to request technical assistance via a form. While Eko offers a Help Center and various contact methods, some customer reviews indicate potential inconsistencies in their support responsiveness and shipping issues. Therefore, Cleerly appears to have a more clearly defined and potentially more reliable support structure.